The HRS-AKI (versus non–HRS-AKI) group more frequently received HRS-specific vasoconstrictors (81.5% versus 67.9%, P = 0.03) and albumin during admission (96.9% versus 84.0%, P = 0.007). Here, ALB is linked to acute kidney injury.